跳至主要内容
临床试验/NCT04610190
NCT04610190已完成不适用

Useability Test of Gait Enhancing and Motivating System-Hip (GEMS-H)

Yun-Hee Kim2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年11月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Yun-Hee Kim
入组人数
20
试验地点
2
主要终点
Change in 10 meter walk test from baseline in gait speed

研究概览

简要总结

The purpose of this study is to investigate the userbility and satisfaction of functional gait training with the Gait Enhancing and Motivating System-Hip type (GEMS-H) on locomotor function in normal adults including the elderly.

详细描述

The GEMS-H is a hip-type assist device developed by the Samsung Advanced Institute of Technology. The GEMS-H is worn around the waist and fastened at the waist and thighs by a set of belts with velcro to assist motion at the hip joints. The device weighs 2.1kg, and has 2 brushless direct current motors running on a rechargeable lithium ion battery. The normal operation time for the device is 2 hours. The GEMS-H is available in three sizes to fit various waist/hip sizes: small, medium, and large. The width of each version can be adjusted further to fit individual body size within the circumference range. Also, the thigh frames are available in three sizes (large, medium, and small) for different leg lengths. It is controlled through a custom built application on a hand held tablet.

Participants will be normal adults with community-dwelling older adults aged 19-85.

Participants will be scheduled for 24 training sessions of training plus 3 sessions of testing (pre-training, mid-test after the 12 sessions of training, post-training).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
19 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 19 - 85 years
  • Living in the community-dwelling with ability to travel to the intervention site to participate in the training program.

排除标准

  • Difficult to understand experimental tasks because of extremely severe cognitive impairment (Korean-Mini-Mental State Examination, K-MMSE≤10)
  • Serious cardiac conditions (hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living)
  • BMI ≥ 35 kg/m2
  • Serious medical conditions including myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living, Severe hypertension, severe weight bearing pain, life expectancy less than one year

结局指标

主要结局

Change in 10 meter walk test from baseline in gait speed

时间窗: session 0 (initial visit); after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks)

Measure of self selected speeds by measuring the time it takes an individual to walk 10 meters. To perform the test, patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: "Please walk this distance at your normal pace when I say go."

次要结局

  • Change in Muscle Strength from Baseline(session 0 (initial visit); after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks))
  • User Satisfaction Questionnaire(after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks))
  • Changes in Functional Reach Test (FRT) from baseline(session 0 (initial visit); after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks))
  • Changes in Short Physical Performance Battery (SPPB) from baseline(session 0 (initial visit); after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks))
  • Change in Berg Balance Scale (BBS) from baseline in balance(session 0 (initial visit); after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks))
  • Changes in EuroQol-5D (EQ-5D) from baseline(session 0 (initial visit); after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks))
  • Changes in Fall Efficacy Scale-Korean (FES-K) from baseline(session 0 (initial visit); after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks))
  • Change in Timed Up and Go test (TUG) from baseline in balance(session 0 (initial visit); after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks))
  • Change in Geriatric Depression Scale (GDS) from Baseline(session 0 (initial visit); after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks))
  • Changes in Four Square Step Test (FSST) from baseline(session 0 (initial visit); after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks))
  • Change in 6 minute walk test (6MWT) from Baseline(session 0 (initial visit); after session 12 (at approximately 4 weeks); after session 24 (at approximately 8 weeks))

研究者

发起方
Yun-Hee Kim
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yun-Hee Kim

Professor

Samsung Medical Center

研究点 (2)

Loading locations...

相似试验